Name |
EditForce, Inc. |
Established |
May 15, 2015 |
Capital |
JPY 90,000,000 |
President and CEO |
Takashi Ono |
Head office |
3-8-33, Momochihama, Sawara-ku, Fukuoka City, Fukuoka, 814-0001 JAPAN |
Fukuoka Laboratory |
West Zone 5 #430, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka City, Fukuoka, 819-0395 JAPAN
TEL+81-92-802-4935 |
Tokyo Office |
9F Saiwai Bldg, 1-3-1 Uchisaiwai-cho Chiyoda-ku, Tokyo, 100-0011 JAPAN
TEL+81 50-5444-5960 |
Business area |
Drug discovery utilizing gene editing technology and licensing of PPR Platform Technology |
Major investors |
- KISCO LTD.
- UTEC 3 Limited Partnership (The University of Tokyo Edge Capital Partners Co., Ltd.)
- Newton Biocapital I Pricaf privée SA (Newton Biocapital Partners SPRL)
- Technology Ventures IV Venture Capital Investment Limited Partnership (ITOCHU Technology Ventures, Inc.)
- MP Healthcare Venture Management, Inc.
- Kyushu Regional Recovery Support Fund (Regional Economy Vitalization Corporation of Japan)
|